CORRELATION OF NEOPTERINE AND IFNγ LEVELS IN THE PATIENTS WITH EXACERBATION OF CHRONIC PERIODONTITIS AND INTOLERANCE OF DENTAL MATERIALS

Studies of potential biomarkers in periodontology are focused on analysis of oral liquid which revealed a number of potential salivary periodontitis biomarkers. The biomarkers should be simple to perform, with easily interpretable results providing relevant information from initial stages of disease, to measure its activity, thus reflecting the disease evolution (e.g., from gingivitis to periodontitis). However there are some more scientific, clinical and technological tasks to develop successful clinical salivary diagnostics for periodontitis treatment. The purpose of our study was to assess interrelations of IFNγ and neopterine in oral fluid of the patients with chronic generalized periodontitis (CGP), aiming for more complete understanding of periodontal disorders and at patients with an intolerance of stomatologic materials. It is shown that the average levels of neopterine in exacerbated moderate-stage CGP patients was raised before treatment to 11.6 [8.0; 15.4] ng/ml, as compared with post-treatment level of 5,5 [4,1; 7,1] ng/ml (р < 0.05) Average amount of IFNγ in oral fluid from these patients group was 6.7 [5.0; 8.7] pg/ml before treatment, as compared to 5.5 [3.5; 7.1] pg/ml after treatment (no significant difference). Neopterine level in patients with exacerbated severe CGP before treatment was even higher than in patients of moderate/severe group, with an average of 8.2 [6.0; 9.9] ng/ml thus sufficiently exceeding post-treatment levels, i.e., 5.5 [4.1; 7.1] ng/ml (р < 0.05). A course of periodontal therapy in this group was associated with sufficient changes of IFNγ levels in oral fluid: appropriate levels before and after treatment were, respectively, 8.6 [7.3; 11.2] pg/ml, and 5.4 [4.3; 6.7] pg/ml. We have revealed that the OHI-S and SBI indexes characterizing conditions of oral cavity are interconnected with local neopterine and IFNγ levels. It is shown that an increased neopterine concentration in oral fluid and its correlation with SBI index in CGP patients is an independent biomarker of therapeutic effect. The patients with a CGP exhibited a highly significant correlation between initial levels of IFNγ and neopterine in oral fluid (R = 0.82; p = 0.0001), and after treatment (R = 0.78; p = 0.0001) in both groups of the patients.

Level of a neopterin and IFNγ at patients with complaints to intolerance of dentoprosthetic materials before removal of artificial limbs and after removal of orthopedic designs authentically didn't change.

1. Артюшкевич А.С., Латышева С.В., Наумович С.А. Заболевания периодонта. М.: Мед. лит., 2006. 328 с. [Artyushkevich A.S., Latysheva S.V., Naumovich SA. Periodontal diseases]. Moscow: Medical Literature, 2006. 328 p.

2. Дедова Л.Н., Лапицкая А.В. Быстропрогрессирующий периодонтит: методы лечения. Ч. 2 // Стоматолог, 2014. № 1. С. 11-16. [Dedova L.N., Lapitskaya A.V. Aggressive periodontitis: current methods (part 2). Stomatolog = Stomatologist, 2014, no. 1, pp. 11-16. (In Russ.)]

3. Лебедев М.Ю., Пученкина Е.В. Динамика изменений содержания неоптерина и интерферона-гамма в сыворотке крови у пациентов с ожоговой травмой // Фундаментальные исследования, 2012. № 12-2. С. 294-297. [Lebedev M.Y., Puchenkina E.V. The dynamics of serum levels of neopterin and interferon-gamma in burn patients. Fundamental`nye issledovaniya = Fundamental Research, 2012, no. 12-2, pp. 294-297. (In Russ.)]

4. Пустовалова Р.А., Петрова М.Б. Неоптерин как показатель активности воспалительного этапа раневого процесса в коже // Биомед. Химия, 2011. Т. 57, вып. 4. С. 461-468. [Pustovalova R.A., Petrova M.B. Neopterine as an indicator of activity of an inflammatory stage of a wound process in a skin. Biomed. Himiya = Biomed. Chemistry, 2011, Vol. 57, no. 4, pp. 461-468. (In Russ.)]

5. Baum B.J. Scientific frontiers: emerging technologies for salivary diagnostics. Adv. Dent. Res., 2011, Vol. 23, no. 4, pp. 360-368.

6. Beksac K. Evaluation of pro-inflammatory cytokine and neopterin levels in women with papillary thyroid carcinoma. Int. J. Biol. Markers, 2016, pp. 10-16.

7. Billiau A., Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev., 2009, Vol. 20, no. 2, pp. 97-113.

8. Buduneli N., Kinane D.F. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J. Clin. Periodontol., 2011, Vol. 38, Suppl. 11, pp. 85-105.

9. Horz H.-P., Conrads G. Diagnosis and anti-infective therapy of periodontitis. Expert. Rev. Anti-Infect. Ther., 2007, Vol. 5, no. 4, pp. 703-715.

10. Löe H., Anerud A., Boysen H., Morrison E. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J. Clin. Periodontol., 1986, Vol. 13, no. 5, pp. 431-445.

11. Loos B.G., Tjoa S. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontology, 2005, Vol. 39, pp. 53-72.

12. Magnus M.C. Maternal plasma total neopterin and kynurenine/tryptophan levels during pregnancy in relation to asthma development in the offspring. J. Allergy Clin. Immunol., 2016, pp. 68-76.

13. Muller T.F. Low serial serum neopterin does not predict low risk for chronic renal graft rejection. Pediatr. Nephrol., 2001, Vol. 16, pp. 11-14.

14. Ozmeriç N. Baydar T., Bodur A., Ayse B.E., Ahu U., Kaya E., Sahin G. Level of neopterin, a marker of immune cell activation in gingival crevicular fluid, saliva, and urine in patients with aggressive periodontitis. Periodontol., 2002, Jul, Vol. 73, no. 7, pp. 720-725.

15. Preshaw P.M., Taylor J.J. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J. Clin. Periodontol., 2011, Vol. 38, Suppl. 11, pp. 60-84.

16. Wong, D.T. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J. Am. Dent. Assoc., 2006, Vol. 137, no. 3, pp. 313-321.

17. Zia A., Khan S., Bey A., Gupta N.D., Mukhtar-Un-Nisar S. Oral biomarkers in the diagnosis and progression of periodontal diseases. Biol. Med., 2011, Vol. 3, no. 2, pp. 45-52.